India 2007 © Sheila Shettle/MSF
The "Drop the Case" campaign called for drug giant Novartis to drop its legal case aimed at gutting India’s patent law of important public health safeguards.
For six years the drug company Novartis has refused to back down on its legal case to stop the production of affordable generic medicines in India. MSF with others continues its resolute opposition to this attack on life-saving medicines that save millions of lives in developing countries.

The Indian Supreme Court's landmark decision to uphold India's Patents Act in the face of the seven-year challenge by Swiss pharmaceutical company Novartis is a major victory for patients' access to affordable medicines in developing countries.
India 2012 © MSF

India 2007 © Sheila Shettle/MSF
The "Drop the Case" campaign called for drug giant Novartis to drop its legal case aimed at gutting India’s patent law of important public health safeguards.
India 2011 © Guddu
Thank you to the more than 20,000 people who sent messages calling for Novartis to put the lives of people before profits.
26 March 2013
Update: Verdict in Novartis vs India case on patents and access to medicines due Monday 1 April
21 December 2012
HIV+ People and MSF Protest Outside Novartis Headquarters In Mumbai Ahead of Verdict in Novartis Vs. India Supreme Court Case
04 December 2012
Novartis vs. India: Supreme Court hearing ends
16 November 2012
Update on Novartis vs India, Supreme Court Case
19 September 2012
STOP NOVARTIS: Flashmob in Geneva

© MSF
Leena Menghaney, who works for the Access Campaign in New Delhi, describes one of the biggest challenges facing activists campaigning about the Novartis trial.

Switzerland 2007 © MSF
Nearly half a million people, including Archbishop Desmond Tutu, author John Le Carré and former Swiss President Ruth Dreifuss, signed our petition calling on Novartis to ‘Drop the Case’ in 2006.